Persistent Asset Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Persistent Asset Partners's BMY Position: Q3 2026 in Review
Persistent Asset Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 50 shares — an estimated $3.16K sold.
Persistent Asset Partners first reported a position in BMY in Q3 2025 and held it in 2 quarters. The position peaked at $1.34M in Q3 2025. 2,566 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Persistent Asset Partners reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Persistent Asset Partners sold 50 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.16K.
- Persistent Asset Partners first reported a position in Bristol-Myers Squibb in Q3 2025 and held it in 2 quarters.
- Persistent Asset Partners's Bristol-Myers Squibb position peaked at $1.34M in Q3 2025.
- 2,566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.